abstract |
A pharmaceutical composition in the form of a dispersible tablet comprising a solid dispersion of 40-O- (2-hydroxy) ethyl-rapamycin, a disintegrant comprising cross-linked polyvinylpyrrolidone and colloidal silicon dioxide, wherein the composition comprises 1 to 5% of colloidal silicon dioxide by weight. |